The Scientists’ Channel is an independent video platform for scientists, clinicians, and laboratory experts around the world to share the latest innovations in their fields. From clinical diagnostics to NMR to cell culture, hear from leading researchers about which technologies and techniques they use to advance their work. To keep up with the excitement of multiple scientific communities, The Scientists’ Channel takes you behind the scenes of the major annual conferences, from SLAS to Pittcon, and this summer launched a new Cannabis Testing channel to keep you at the cutting edge of this growing industry. As we approach the end of the year, here we bring you our top ten The Scientists’ Channel interviews from 2019:
Dr. Sofia Forslund, junior group leader at ECRC (MDC/Charité, Berlin), explains how she hopes that the modeling of missing microbial data will lead to more personalized therapeutics for conditions such as hypertension. Forslund also highlights the importance of avoiding contamination during vital research procedures and explains the necessity of equipment such as NuAire's biosafety cabinets.
Prof. Zobair M. Younossi, Professor and Chairman of the Department of Medicine at Inova Fairfax Hospital in Falls Church, Virginia, talks about the epidemiology of non-alcoholic fatty liver disease (NAFLD), addressing why there is a global need for more awareness and why the current approach to clinical care needs to change.
Professor Christian Griesinger, Head of NMR-Based Structural Biology at the Max Planck Institute for Biophysical Chemistry, is using ultra-high field NMR to investigate intrinsically disordered proteins (IDPs). The structure of IDPs is important in diseases such as neurodegenerative diseases and Griesinger's research allows the function, or malfunction, of such IDPs to be investigated.
Dr. Nathaly Reyes Garcés and Colton Myers explain how Restek is overcoming challenges in the cannabis testing industry by helping to create bespoke workflows and method development in the face of ongoing changes within the industry, new regulations coming into place, and state-to-state differences in the United States.
Dr. Jonathan Speare, from White Buffalo Laboratories, discusses quality assurance requirements and outlines how quantifying marijuana testing is changing the cannabis industry. Speare explains how Waters helps White Buffalo Laboratories test for different cannabinoids and other chemicals such as pesticides and mycotoxins and how these tests can be used to provide a safe product.
We hear from Nobel laureate Sir Fraser Stoddart about the most recent discoveries, studies, and technologies in chemistry. Stoddart, along with Jean-Pierre Sauvage and Ben Feringa, won the 2016 Nobel Prize in Chemistry for the design and synthesis of artificial molecular machines.
Dr. Ankur Srivastava, Consultant Gastroenterologist and Hepatologist at Southmead Hospital, North Bristol Trust, U.K., discusses his two-step primary care pathway approach of utilizing non-invasive tests to reduce unnecessary referrals and improve detection of severe disease in patients with non-alcoholic fatty liver disease (NAFLD).
Find out how one dedicated scientist at the University of Puerto Rico kept his lab’s prized Bruker NMR running in the wake of one of the most destructive hurricane seasons on record. Dr. Melvin De Jesus Flores describes how his efforts following Hurricane Maria in 2017 led to him successfully saving his NMR and won him a Scientists' Choice Award, along with Bruker.
Dr. Tatyana Polenova from the University of Delaware is using solid-state NMR spectroscopy to look at the molecular structure of viruses with atomic resolution. Polenova explains how her work is providing fundamental insight into the structure of HIV, pushing forward understanding of the virus, and helping to advance the development of a cure for the disease.
Dr. Aleksandra Dukic, a postdoctoral researcher at the Institute for Cancer Research, Oslo University Hospital, describes a novel target for inhibiting glioblastoma cancer invasion into surrounding brain tissue and the importance of this work in addressing the need for innovative therapeutics to combat this aggressive cancer.